Telix Pharmaceuticals LtdTLXEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Telix Pharmaceuticals Ltd is a global clinical-stage biopharmaceutical company specializing in the development and commercialization of targeted radiopharmaceutical products for oncology. Its core portfolio covers diagnostic imaging agents and therapeutic treatments for prostate, renal, and neuroendocrine cancers, serving markets across North America, Europe, and Asia-Pacific.
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-03-29 | Smith Darren Charlton | Group Chief Financial Officer | Option exercise | 1.1K | $0.00 | $0 |
1–1 of 1